GB0722274D0 - New therapeutic method - Google Patents

New therapeutic method

Info

Publication number
GB0722274D0
GB0722274D0 GBGB0722274.8A GB0722274A GB0722274D0 GB 0722274 D0 GB0722274 D0 GB 0722274D0 GB 0722274 A GB0722274 A GB 0722274A GB 0722274 D0 GB0722274 D0 GB 0722274D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic method
new therapeutic
new
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0722274.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
University of Oxford
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
University of Oxford
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, University of Oxford, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Priority to GBGB0722274.8A priority Critical patent/GB0722274D0/en
Publication of GB0722274D0 publication Critical patent/GB0722274D0/en
Priority to PCT/GB2008/051059 priority patent/WO2009063241A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0722274.8A 2007-11-13 2007-11-13 New therapeutic method Ceased GB0722274D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0722274.8A GB0722274D0 (en) 2007-11-13 2007-11-13 New therapeutic method
PCT/GB2008/051059 WO2009063241A1 (en) 2007-11-13 2008-11-13 3-hydroxyanthranilic acid or salts thereof1 for treating cancer or infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0722274.8A GB0722274D0 (en) 2007-11-13 2007-11-13 New therapeutic method

Publications (1)

Publication Number Publication Date
GB0722274D0 true GB0722274D0 (en) 2007-12-27

Family

ID=38896230

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0722274.8A Ceased GB0722274D0 (en) 2007-11-13 2007-11-13 New therapeutic method

Country Status (2)

Country Link
GB (1) GB0722274D0 (en)
WO (1) WO2009063241A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016291817A1 (en) 2015-07-16 2018-02-22 Biolinerx Ltd. Compositions and methods for treating cancer
CN110613713B (en) * 2018-06-20 2022-07-22 上海交通大学医学院 3-hydroxyaminobenzoic acid and sorafenib combined medicine for treating tumor
WO2023086364A1 (en) * 2021-11-09 2023-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Composition containing 3-hydroxyanthranilic acid and compounds that alter iron homeostasis and method of its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002535A1 (en) * 1998-10-28 2000-05-24 Hrissanthi Ikonomidou New use of glutamate antagonists for the treatment of cancer
EP1369114A1 (en) * 2002-06-07 2003-12-10 Peter Priv. Doz. Dr. Terness Use of tryptophan metabolites as pharmaceutical agents
US20060089316A1 (en) * 2004-10-25 2006-04-27 Brown Truman R Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
BRPI0518432A2 (en) * 2004-11-17 2008-11-25 Angiogen Pharmaceuticals Pty L Method of Modulating Cell B Operation

Also Published As

Publication number Publication date
WO2009063241A1 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
GB0713896D0 (en) Method
GB0712395D0 (en) Method
GB0707096D0 (en) Method
GB0803477D0 (en) Therapy selection method
IL201054A0 (en) New methods
GB0719518D0 (en) Therapy
GB0703366D0 (en) Method
GB0710321D0 (en) Method
GB0708960D0 (en) Method
GB0718684D0 (en) Treatment method
GB0714338D0 (en) method
GB0711843D0 (en) Method
GB0705321D0 (en) Method
GB0722274D0 (en) New therapeutic method
GB0607153D0 (en) Therapeutic Method
GB0710519D0 (en) Method
GB0714239D0 (en) Method
GB0706833D0 (en) Method
GB0716072D0 (en) Therapy
GB0711140D0 (en) New methods
GB0700635D0 (en) Therapy
GB0710398D0 (en) Method
GB0715307D0 (en) Therapeutic method
GB0814479D0 (en) Therapeutic method
GB0721009D0 (en) New therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)